...
首页> 外文期刊>Biological psychiatry >Brain-behavior biomarkers of illness and illness risk in bipolar disorder: Present findings and next steps
【24h】

Brain-behavior biomarkers of illness and illness risk in bipolar disorder: Present findings and next steps

机译:躁郁症疾病和疾病风险的脑行为生物标志物:目前的发现和下一步

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Identifying biomarkers denoting risk for future psychiatric illnesses such as bipolar I disorder (BD-I) is a critically important goal for psychiatric research. The huge advances in neuroima-ging techniques have facilitated increasingly more sophisticated examination of the complex abnormalities in neural circuitry relevant to these illnesses and have provided the field with potential neural biomarkers of illnesses such as BD-I. Yet despite the increasing number of neuroimaging studies in BD-i, the extent to which these abnormalities represent markers of risk for, versus consequences of, the illness remains unclear. Studying unaffected, yet at-risk, individuals and probands with BD-I allows for a differentiation between these two types of biomarker. Linke et al. (1) report one of the first such studies using diffusion imaging (DI).
机译:鉴定表示未来精神疾病如双相性精神障碍(BD-I)风险的生物标志物是精神病学研究的重要目标。神经成像技术的巨大进步促进了对与这些疾病有关的神经回路复杂异常的日益复杂的检查,并为该领域提供了诸如BD-1等疾病的潜在神经生物标记。尽管在BD-i中进行神经影像学研究的人数不断增加,但这些异常在多大程度上代表了疾病风险和后果的标志,目前尚不清楚。对未受影响但仍处于危险中的BD-I个人和先证者进行研究可以区分这两种类型的生物标志物。林克等。 (1)报告了使用扩散成像(DI)进行的首批此类研究之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号